CDSCO has no safety studies for reducing the recc. age from 9 mo. to 6 mo. and additional dose
Reply received on 13th September 2022.
ICMR has not conducted any study to assess the transmission potential of SARS-CoV-2 in vaccinated vs unvaccinated individuals. Therefore, the requested information
RTI presentation (Updated 14 March 2022) prepared by Awaken India Movement RTI team.
There is no specific protocol for purification and isolation of the sars-cov-2 Delta variant
In an RTI to ICMR-National Institute of Virology (NIV), Pune, it was queried as follows:“What is the pore size of the standard
This RTI shows skew of asymptomatic vs symptomatic cases and acceptance of ICMR that frequent testing can lead to injury.
Consult Doctor for concerns with Covid Vaccination and no compensation for adverse events following Covid Vaccine.
Covid 19 vaccine clinical trials are still ongoing for conclusion of results of complete safety, immunogenicity and efficacy”
No Clinical trials for vaccines in post diseased individuals